Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Mucosa | 3 | 2018 | 219 | 0.790 |
Why?
|
| Intestinal Obstruction | 1 | 2018 | 36 | 0.670 |
Why?
|
| Intestine, Small | 1 | 2018 | 89 | 0.650 |
Why?
|
| Gaucher Disease | 1 | 2018 | 60 | 0.640 |
Why?
|
| Membrane Glycoproteins | 6 | 2017 | 370 | 0.630 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2017 | 5 | 0.600 |
Why?
|
| Hepatitis | 1 | 2017 | 25 | 0.590 |
Why?
|
| Membrane Proteins | 4 | 2020 | 617 | 0.470 |
Why?
|
| Heart Transplantation | 1 | 2017 | 328 | 0.470 |
Why?
|
| Carcinogenesis | 4 | 2020 | 124 | 0.420 |
Why?
|
| Colonic Neoplasms | 4 | 2019 | 299 | 0.360 |
Why?
|
| Blood Platelets | 2 | 2020 | 284 | 0.340 |
Why?
|
| Colorectal Neoplasms | 3 | 2020 | 560 | 0.340 |
Why?
|
| Colitis | 4 | 2019 | 156 | 0.320 |
Why?
|
| Heart Failure | 1 | 2017 | 1179 | 0.310 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 199 | 0.290 |
Why?
|
| Gastrointestinal Tract | 2 | 2017 | 62 | 0.260 |
Why?
|
| Homeostasis | 2 | 2017 | 291 | 0.240 |
Why?
|
| Inflammation | 3 | 2019 | 1030 | 0.200 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 14 | 0.180 |
Why?
|
| Immune Evasion | 1 | 2020 | 19 | 0.180 |
Why?
|
| Hemoglobins | 1 | 2020 | 120 | 0.180 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.180 |
Why?
|
| Thrombin | 1 | 2020 | 117 | 0.180 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2018 | 7 | 0.170 |
Why?
|
| Autopsy | 1 | 2018 | 56 | 0.170 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 36 | 0.170 |
Why?
|
| Complement Activation | 1 | 2020 | 145 | 0.160 |
Why?
|
| Complement System Proteins | 1 | 2020 | 135 | 0.160 |
Why?
|
| Fatal Outcome | 1 | 2018 | 164 | 0.160 |
Why?
|
| Glucosylceramidase | 1 | 2018 | 50 | 0.160 |
Why?
|
| Immune Tolerance | 1 | 2019 | 114 | 0.160 |
Why?
|
| Mice, Knockout | 6 | 2020 | 1692 | 0.160 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 91 | 0.160 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 28 | 0.160 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 163 | 0.150 |
Why?
|
| CD11c Antigen | 1 | 2017 | 18 | 0.150 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 70 | 0.150 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 49 | 0.150 |
Why?
|
| Thymectomy | 1 | 2017 | 11 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 265 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2018 | 185 | 0.140 |
Why?
|
| Tumor Escape | 1 | 2016 | 37 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 94 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 216 | 0.140 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 475 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2014 | 81 | 0.140 |
Why?
|
| Sirolimus | 1 | 2017 | 118 | 0.140 |
Why?
|
| Prognosis | 5 | 2020 | 2093 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 2 | 2014 | 148 | 0.140 |
Why?
|
| Sepsis | 1 | 2018 | 233 | 0.140 |
Why?
|
| Tacrolimus | 1 | 2017 | 127 | 0.130 |
Why?
|
| Mice | 9 | 2020 | 8472 | 0.130 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2015 | 38 | 0.130 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 329 | 0.130 |
Why?
|
| Animals | 12 | 2020 | 20877 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 84 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2017 | 682 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 384 | 0.120 |
Why?
|
| Melanosomes | 1 | 2013 | 5 | 0.120 |
Why?
|
| Skin Pigmentation | 1 | 2013 | 25 | 0.120 |
Why?
|
| Melanins | 1 | 2013 | 24 | 0.120 |
Why?
|
| Humans | 14 | 2020 | 68525 | 0.120 |
Why?
|
| alpha Karyopherins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Female | 8 | 2020 | 38015 | 0.120 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2013 | 18 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 49 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 326 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 514 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 595 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 57 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 756 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 163 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1293 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2017 | 235 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 2790 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 498 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 334 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 292 | 0.090 |
Why?
|
| Young Adult | 2 | 2018 | 5708 | 0.090 |
Why?
|
| Macrophages | 1 | 2013 | 647 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 508 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 1118 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 126 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2016 | 954 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2020 | 179 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 532 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1533 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 1660 | 0.070 |
Why?
|
| Survival Rate | 2 | 2020 | 1055 | 0.070 |
Why?
|
| Child | 1 | 2017 | 6400 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 132 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1037 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1032 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1174 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1173 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 1752 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 710 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 2550 | 0.050 |
Why?
|
| Complement Pathway, Classical | 1 | 2020 | 22 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2020 | 110 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 242 | 0.040 |
Why?
|
| Leukemia | 1 | 2020 | 117 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 59 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 211 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 523 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2020 | 201 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 38 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 245 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 2688 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 79 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 1027 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 53 | 0.040 |
Why?
|
| Heterografts | 1 | 2016 | 70 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 138 | 0.040 |
Why?
|
| SEER Program | 1 | 2016 | 150 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 21119 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 492 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 536 | 0.030 |
Why?
|
| Male | 4 | 2020 | 37281 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 10 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2014 | 15 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 791 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 66 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 252 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2013 | 62 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 37 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2013 | 28 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 31 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2013 | 52 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Carcinogens | 1 | 2013 | 86 | 0.030 |
Why?
|
| DNA Repair | 1 | 2013 | 127 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 127 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 88 | 0.030 |
Why?
|
| Colon | 1 | 2013 | 168 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 217 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.030 |
Why?
|
| Data Mining | 1 | 2013 | 45 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 218 | 0.030 |
Why?
|
| Workflow | 1 | 2013 | 100 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 199 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1640 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 14842 | 0.030 |
Why?
|
| Acute Disease | 1 | 2013 | 658 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 799 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 770 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1849 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 513 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 866 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1663 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2013 | 753 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1329 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 902 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 624 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 561 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4843 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 8903 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 21375 | 0.010 |
Why?
|